Industrial pharmaceutical pipettes on machine

UK-Japan trade agreement to bolster pharmaceutical industry

As part of a wide-reaching future trade deal struck between the UK Government and Japan last week, pharmaceutical companies from both countries will be able to largely continue to operate as normal come January 1, 2021.

With the UK set to exit the European Union at the end of the year, a number of new trade agreements with international partners are being struck to ensure the UK is largely unaffected economically. This includes aspects of the deals which directly impact the health and pharmaceutical industries.

In 2019, the UK exported £23.3bn worth of pharmaceutical goods.

Japan received 3.3% of those goods, to a value of £760m, making pharmaceutical goods the third-highest good in terms of value exported between the UK and Japan.

Crucially, as part of the newly-agreed Free Trade Agreement between the two countries, the UK and Japan will incorporate the functions of the existing EU/Japan Mutual Recognition Agreement (MRA) for medicines, meaning both sides will continue to accept each other’s drug safety testing and inspections before export.

Having an MRA in place avoids unnecessary duplication, disruption to supply chains or delays to patient access to medicine.

In response to the agreed deal, Claire Machin, Head of International Policy at the ABPI, said: “The UK-Japan agreement provides much-needed continuity to businesses in our sector as they focus on preparations for the end of the Transition Period.

“These early deals are an opportunity for the Government to set out a future trade agenda which supports innovative British industries, encourages R&D investment and strengthens the UK’s role as a leader in life sciences. We look forward to working with them to achieve that in future agreements."

Read more about Brexit and it's impacts on healthcare through our dedicated Brexit Resource Hub:

Brexit series - Boris Johnson banner

 

NHE Jan.Feb 21

NHE Jan/Feb 21

Creating a net zero NHS

NHE’s Jan/Feb 2021 edition focuses on the role of pharma working alongside the NHS, how we are working to digitise the health service and the ways in which the NHS can be involved in addressing the climate emergency.

Videos...

View all videos
BMC Whitepaper

Survey

How well do the NHS understand digital potential?

Recently we have been gathering primary data direct from those within the NHS on modernising NHS technology and the challenges faced around resource, training and service management.

Download the full whitepaper and read the full findings in our exclusive report to learn more.

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all